On April 9, 2012, the Board of Directors of FluoroPharma Medical, Inc. decided to eliminate Dr. Elmaleh's status with the company as an executive officer, but will continue to retain his services as a consultant to the company. Dr. Elmaleh will also continue to serve as a director of the company and as Chairman of the Board.